GLP-1 Drugs Improve Metabolic Outcomes in Cushing's Syndrome Without ...
TodayCushing's syndrome presents with marked metabolic abnormalities such as obesity,insulinresistance, diabetes mellitus, and dyslipidemia, which are major risk factors for cardiovascular diseases. Based on the results of the study,GLP-1RAs show clear benefits for improving metabolism in a high-risk patient population, potentially serving as a new therapeutic tool for the management of ...
source: https://medicaldialogues.in